174 related articles for article (PubMed ID: 16740716)
1. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
Yoshida A; Takemura H; Inoue H; Miyashita T; Ueda T
Cancer Res; 2006 Jun; 66(11):5772-80. PubMed ID: 16740716
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
3. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
4. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
8. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
Friesen C; Kiess Y; Debatin KM
Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
[TBL] [Abstract][Full Text] [Related]
9. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Hayashi K; Takenaka K; Nishimura Y; Sakai N; Nozawa Y
Cell Death Differ; 2000 Sep; 7(9):761-72. PubMed ID: 11042671
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells.
D'Alessio M; Cerella C; Amici C; Pesce C; Coppola S; Fanelli C; De Nicola M; Cristofanon S; Clavarino G; Bergamaschi A; Magrini A; Gualandi G; Ghibelli L
FASEB J; 2004 Oct; 18(13):1609-11. PubMed ID: 15289449
[TBL] [Abstract][Full Text] [Related]
12. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
13. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
14. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways.
Nieves-Neira W; Pommier Y
Int J Cancer; 1999 Jul; 82(3):396-404. PubMed ID: 10399957
[TBL] [Abstract][Full Text] [Related]
16. Temporospatial sequence of cellular events associated with etoposide-induced neuronal cell death: role of antiapoptotic protein Bcl-X(L).
Kim JE; Han BS; Choi WS; Eom DS; Lee EH; Oh TH; Markelonis GJ; Saido TC; Lee GE; Chung IK; Oh YJ
J Neurosci Res; 2001 Dec; 66(6):1074-82. PubMed ID: 11746439
[TBL] [Abstract][Full Text] [Related]
17. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
[TBL] [Abstract][Full Text] [Related]
18. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells.
Troyano A; Sancho P; Fernández C; de Blas E; Bernardi P; Aller P
Cell Death Differ; 2003 Aug; 10(8):889-98. PubMed ID: 12867996
[TBL] [Abstract][Full Text] [Related]
19. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Giuliano M; Lauricella M; Vassallo E; Carabillò M; Vento R; Tesoriere G
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1300-11. PubMed ID: 9660477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
